Match Document Document Title
US20110003760 ABNORMAL PROTEIN REMOVING METHOD  
A method for treating symptoms or diseases associated with accumulation of abnormal protein in the body includes administrating to a subject desiring such treatment a composition containing...
US20130209379 LIP COSMETIC FORMULATIONS  
Cosmetic formulations suitable for application to the lips are described herein. The lip cosmetic formulations can contain at least caffeine, extract of Hoodia gordinii and extract of green tea....
US20110190123 SLOW-RELEASE FORMULATIONS CONTAINING QUILLAY EXTRACTS, FOR CONTROLLING WHEAT TAKE-ALL DISEASE  
This invention refers to natural fungicide used in the treatment of seeds or soil treatment, that were obtained from the formulation of quillay extracts, rich in saponin concentrations, to which...
US20110160152 EXTRACTS OF AQUILARIA HULLS AND USE THEREOF IN THE TREATMENT OF CANCER  
The invention discloses an ethyl acetate layer of methanol extract of Aquilaria hulls for killing cancer cells and treating/preventing cancers and its uses. The extracts of Aquilaria hulls has an...
US20110144044 Composition and method for increasing post workout recovery  
The composition of a dietary supplement is provided for increasing post workout recovery, increasing replenishment and regaining energy following exercise. A method for achieving the same is also...
US20120077763 METHODS FOR TREATING HEART FAILURE BY INHIBITING THE MITOCHONDRIAL SODIUM-CALCIUM EXCHANGER (mNCE)  
Methods and compounds for preventing or reducing the toxic side effects of cardiac glycosides by inhibiting the mitochondrial sodium-calcium exchanger (mNCE) are provided. Methods and compositions...
US20140044799 MOLECULAR SIGNATURE OF CUTANEOUS PIGMENTARY SPOTS, ASSOCIATED WITH THE ORGANIZATION OF THE EXTRACELLULAR MATRIX  
The present invention concerns a molecular signature of cutaneous pigmentary spots, comprising the genes MXRA5, LYZ, CTSL2, PLAU, TIMP1, EFEMP1, ECM1, ASPN, HS3ST6, PAPLN, CHSY1 and FLRT2, and...
US20120196817 METHOD FOR ENHANCING NUTRIENT ABSORPTION WITH ASTRAGALOSIDES  
The present application relates to a method for enhancing absorption of a nutrient in a subject in need thereof with an effective amount of an isolated astragaloside compound.
US20120196816 METHOD FOR ENHANCING NUTRIENT ABSORPTION WITH ASTRAGALOSIDES  
The present application relates to a method for enhancing absorption of a nutrient in a subject in need thereof with an effective amount of an isolated astragaloside compound.
US20110319352 Compounds That Bind Oxysterol Binding Proteins, and Methods of Use Thereof  
The invention relates in part to the discovery that certain CRAMs, such as schweinfurthin A, target OSBPs (a family of oxysterol binding proteins). Because OSBPs have been shown to be integral to...
US20130040001 METHOD OF PROCESSING ANIMAL SKIN  
The present invention provides a method of processing animal skin, comprising the steps of: 1) providing dry animal skin containing 7-38 wt % water; 2) rehydrating and softening the said dry...
US20110311651 CARDENOLIDES FOR THE TREATMENT OF OCULAR CANCER  
The instant invention provides methods of using a class of compounds known as cardenolides in the treatment of proliferative diseases such as cancer. In particular, the instant invention provides...
US20140274923 MIRNAS AS A PROGNOSTIC BIOMARKER IN PEDIATRIC HEART FAILURE  
The present invention provides for methods of predicting progression of pediatric heart failure using miRNA biomarkers, as well as subsequent treatment of patients based on their classification.
US20130267475 Method of Treating Neurological Conditions with Oleandrin  
A method of treating neurological condition in a subject by administration of a cardiac glycoside is provided. Alzheimer's disease, Huntington's disease or stroke are treated by administering a...
US20120321704 Compound sea Cucumber Product, Preparation Method, and Dosage Forms Thereof  
A compound sea cucumber product, preparation method thereof and dosage forms thereof are disclosed. A fresh sea cucumber is cut open, the viscus thereof is taken out, and they are well-cleaned...
US20120156146 Compositions and Methods for Improving the Appearance of Facial Texture  
A method of improving the appearance of facial texture may comprise the step of applying a composition comprising an effective amount of a material that regulates hyaluronic acid synthesis to an...
US20130315983 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER  
The invention provides compositions with low toxicity and high bioavailability for treating cancer or for inhibiting the development of cancer
US20120148510 Compositions and Methods for Improving the Appearance of Facial Pores  
A method of improving the appearance of facial pores is provided. The method includes the step of applying a composition having an effective amount of a material that regulates IL-1 and/or...
US20130023488 METHODS AND COMPOUNDS FOR REDUCING INTRACELLULAR LIPID STORAGE  
Compounds and compositions for reducing intracellular lipid accumulation in a cell are described herein. These compounds are useful for the treatment and prevention of lipid/glycogen disorders, as...
US20130052160 COMPOUNDS AND USES THEREOF TO INDUCE AN IMMUNOGENIC CANCER CELL DEATH IN A SUBJECT  
The present invention relates to the fields of genetics, immunology and medicine. The present invention more specifically relates to in vitro or ex vivo methods for determining the susceptibility...
US20110172172 Method of Treating Neurological Conditions with Cardiac Glycoside  
A method of treating neurological condition in a subject by administration of a cardiac glycoside is provided. Alzheimer's disease, Huntington's disease or stroke are treated by administering a...
US20120295857 EXTRACT OBTAINED BY A COMMERCIALLY VIABLE PROCESS FOR THE EXTRACTION OF FUROSTANOLIC SAPONINS FROM FENUGREEK SEEDS, IN WHICH ONE OF THE COMPOUNDS IN THE EXTRACT IS PROTODIOSCIN  
Disclosed is an extract obtained by a commercially viable process for the extraction of furostanolic saponins from fenugreek seeds, in which one of the compounds in the extract is protodioscin....
US20120003261 DIGOXIN-LIKE FUNGAL GLYCOSIDE WITH CYTOTOXIC PROPERTIES: NOVEL ASSAY AND APPLICATIONS  
The present invention provides methods of isolating cytotoxic metabolites from a fungus, and specific metabolites obtained from such methods. The present invention also provides methods of...
US20140206631 Cardiac Glycoside Analogs in Combination with Emodin for Cancer Therapy  
A method and medicine for treating leukemia or other cancer includes administering to a patient diagnosed with leukemia or other cancer a treatment regimen that includes periodic doses of a...
US20120122807 Cardiac Glycoside Analogs in Combination with Emodin for Cancer Therapy  
A method and medicine for treating leukemia or other cancer includes administering to a patient diagnosed with leukemia or other cancer a treatment regimen that includes periodic doses of a...
US20110236510 PREGNANE GLYCOSIDE COMPOSITIONS AND CARALLUMA EXTRACT PRODUCTS AND USES THEREOF  
Pregnane glycoside or a Caralluma extract including the pregnane glycoside of the present invention can be used for medical purposes and as food additives, such as a treatment of obesity, a...
US20130324485 Method of Determining the Probability of a Therapeutic Response in Cancer Chemotherapy with Cardiac Glycoside  
A prognostic assay and kit and method of use thereof are provided. The kit and assay are used to determine the likelihood of a diseased cell or tissue having a therapeutic response to treatment...
US20120171309 FORMULATIONS AND METHODS FOR INCREASING EFFICACIES AND IMPROVING FLAVORS OF FORMULATIONS CONTAINING GYNOSTEMMA PLANT  
Formulations and methods for increasing efficacies and flavors of jiaogulan (Gynostemma pentaphyllum and related species) by combining materials derived from whole plant with other herbal and...
US20120128798 Method of Treating Neurological Conditions with Extract of Nerium Species or Thevetia Species  
A method of treating neurological condition in a subject by administration of an extract, or fraction or sub-fraction thereof, of Nerium species or Thevetia species is provided, wherein the...
US20110318397 METHOD FOR PREPARING HIGH PURITY GINSENOSIDE RD USING LACTOBACILLUS CASEI AND COSMETIC COMPOSITION FOR ANTI-WRINKLE COMPRISING THE HIGH PURITY GINSENOSIDE RD  
The present invention relates to a method for preparing high-purity ginsenoside Rd using Lactobacillus casei, more particularly to a method for preparing high-purity ginsenoside Rd using...
US20110136750 COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS  
As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating...
US20110136749 COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS  
As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating...
US20120101052 15-THIA STEROID COMPOUNDS AND COMPOSITIONS  
The invention relates to the use of compounds to treat a number of conditions, such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy. Compounds that can be used in the...
US20110218162 15-THIA STEROID COMPOUNDS AND COMPOSITIONS  
The invention relates to the use of compounds to treat a number of conditions, such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy. Compounds that can be used in the...
US20110076278 Modulators of Hypoxia Inducible Factor-1 and Related Uses for the Treatment of Ocular Disorders  
Methods for treatment of ocular disorders using steroids modulate the effects of local and systemic hypoxic events mediated by hypoxia inducible factor-1 (HIF-1). Steroids that are useful as HIF-1...
US20070122503 USE OF EXTRACTS FROM CIMICIFUGA RACEMOSA AND OF TECTORIGENIN AS AN ESTROGEN-TYPE, ORGANOSELECTIVE MEDICAMENT HAVING NO UTEROTROPHIC EFFECT  
The present invention relates to the use of extracts from Cimicifuga racemosa, and of tectorigenin as an estrogen-type, organoselective medicament for the selective treatment and/or prophylaxis of...
US20120208776 ANTI-NEOPLASTIC COMPOSITIONS COMPRISING EXTRACTS OF BLACK COHOSH  
A method is provided for treating, preventing or ameliorating neoplasia in a subject. This method includes administering to the subject an amount of actein or an amount of an extract of black...
US20120071427 NOVEL ANTIDIABETIC FUROSTANOLIC SAPONIN RICH (FSR) FRACTION FROM FENUGREEK SEEDS  
The present invention discloses a novel anti-diabetic composition extracted from fenugreek seeds. The same comprises a furostanolic-saponin-rich fraction (>70%) with approximately 30% protodioscin...
US20100297251 ENCAPSULATED PARTICLES FOR ENTERIC RELEASE  
The present invention provides a system for delivery of an enteric coated active agent generally resistant to disintegration in an neutral environment having one or more active agents encapsulated...
US20150099711 METHOD AND SYSTEM FOR MODIFYING RAW FOODS, AND RAW FOOD PRODUCT MADE THEREBY  
A method for modifying a quality of a fruit includes cutting a live stem attached to a live fruit at a cut distance from the fruit, producing a cut end of the stem, contacting only the cut end of...
US20110142913 COMPOSITION AND METHOD FOR TREATING ATHEROSCLEROSIS, METHOD FOR DETERMINING IF A SUBJECT HAS ATHEROSCLEROSIS AND METHOD OF SCREENING AN ANTI-ATHEROSCLEROTIC DRUG  
The invention provides a method for determining if a subject has atherosclerosis, including: determining an endogenous microRNA-195 expression level of a subject suspected of having...
US20140080772 TREATMENTS FOR MELANOMA  
The present invention relates to mono- and combination therapies for melanoma, and in particular, metastatic melanoma. Drugs for use in such therapies in include RO 31-8220, bafetinib, and cardiac...
US20110319351 TREATING CANCER WITH CARDIAC GLYCOSIDES  
The invention provides methods to treat cancer with cardiac glycosides.
US20100239553 METHODS FOR PROMOTING CELLULAR HEALTH AND TREATMENT OF CANCER  
Systems and methods are provided herein that provide for promoting cellular health and treatment of cancer, and allied diseases such as diabetes and glaucoma.
US20140186295 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER  
Described herein are methods for the treatment of cancer (e.g. melanoma, lung cancer, or other cancers). The methods involve administrating to a subject in need thereof an agonist of the IL-9...
US20110052730 Leaves Extract of Panax sp., a Process of Making the Same and Uses Thereof  
The present invention relates to a composition for improvement of exercise performance, fatigue recovery or prevention of oxidation response comprising Panax species plant leaves extract or...
US20140051652 Treatment for Migraine Headache  
Using a Pharmaceutically Suitable Preparation containing one more Cardio Glycosides such as THEVETIN B, THEVETIN A, PERUVOSIDE, THEVOFOLIN, OLEANDRIN, NERIIFOLIN, THEVETOXIN Derived or Extracted...
US20130324486 METHOD FOR PRODUCING CULTURED ROOT OF PURPLE GINSENG  
The present invention relates to a novel method for processing a cultured root of purple wild ginseng for increasing saponin content and to the cultured root of the purple wild ginseng which is...
US20130209579 THERAPEUTIC COMBINATION FOR THE TREATMENT OF CANCER  
This invention relates to therapeutic combinations comprising a platinum-based anti-neoplastic agent, such as cisplatin, and an extract from a species of the genus Nerium, such as Nerium oleander,...
US20110275558 LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS  
The present invention relates to the field of medical treatments for diseases and disorders. More specifically, the present invention relates to the use of the lanthionine synthetase component...